Top 50 Biotech Startup Investors in Austria (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
XISTA Science Ventures
VC Fund
|
12 | Austria, France, Slovenia | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $511k–$20M |
|
xista science ventures
VC Fund
|
9 | Austria, Slovenia | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $511k–$20M |
|
tecnet equity
VC Fund
|
7 | Austria | Seed, Series A | Software, SaaS, Biotechnology | $400k–$6M |
|
SOSV
VC Fund
|
5 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
austria Wirtschaftsservice (aws)
VC Fund
|
5 | Austria, Belgium | Seed, Grant, Pre-Seed | Software, SaaS, Information Technology | $44k–$2.7M |
|
MIG Capital
VC Fund
|
4 | Germany, France, Austria | Series A, Series B | Biotechnology, Health Care, Therapeutics | $1.6M–$54M |
|
Schnidar Harald
Angel
|
3 | Austria | Seed, Angel, Pre-Seed | mHealth, Software, Biopharma | |
|
aws Gründungsfonds
VC Fund
|
3 | Austria, Germany, United States | Seed, Series A | Software, SaaS, Information Technology | $1.1M–$12M |
|
Übermorgen Ventures
VC Fund
|
2 | Germany, Switzerland, Finland | Seed, Pre-Seed, Series A | Software, Energy, Renewable Energy | $344k–$12M |
|
10x Founders
VC Fund
|
2 | Germany, United States, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $1.1M–$60M |
|
red-stars.com
VC Fund
|
2 | Austria, Germany | Seed, Series A | Software, Biotechnology, Telecommunications | $1.6M–$4.4M |
|
Gamma Capital Partners
VC Fund
|
2 | Austria, United States, Germany | Series A, Seed | Software, Manufacturing, Information Technology | $406k–$8M |
|
Arax Capital Partners
VC Fund
|
2 | Austria | Seed | Biotechnology, Health Care, Medical | |
|
R42 Group
VC Fund
|
2 | United Kingdom, United States, Austria | Seed, Pre-Seed | Biotechnology, Health Care, Software | $439k–$8M |
|
PUSH VC
VC Fund
|
2 | Austria, Germany, United States | Seed, Series A | Software, Apps, Health Care | $650k–$32M |
|
bmp Ventures
VC Fund
|
2 | Germany, United States, Austria | Seed, Series A | Software, Information Technology, Manufacturing | $30k–$5.9M |
|
The Austrian Research Promotion Agency (FFG)
VC Fund
|
2 | Austria, United States, Belgium | Grant, Seed, Pre-Seed | Software, Artificial Intelligence, Medical | $67k–$3.5M |
|
Aescap Venture
VC Fund
|
2 | United Kingdom, Austria, Belgium | Series A, Series B | Biotechnology, Pharmaceutical, Chemical | $1.5M–$33M |
|
VP Venture Partners
VC Fund
|
2 | Austria, Switzerland | Seed | Medical, Health Diagnostics, Internet | $3M–$3.3M |
|
APEX Ventures
VC Fund
|
2 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $511k–$21M |
|
TSVC
VC Fund
|
2 | United States, China, Canada | Seed, Series A | Software, Artificial Intelligence, Health Care | $500k–$27M |
|
BackBone Ventures
VC Fund
|
2 | Switzerland, Germany, Israel | Pre-Seed, Seed, Series A | Artificial Intelligence, Information Technology, Software | $583k–$105M |
|
eQventure
VC Fund
|
2 | Austria, Switzerland | Seed, Series A | Software, Information Technology, Artificial Intelligence | $549k–$6.6M |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $573k–$22M |
|
FPS-Holding
VC Fund
|
2 | Austria | Seed | Biotechnology, Health Diagnostics | $420k–$429k |
|
Longevitytech.fund
VC Fund
|
2 | United States, United Kingdom, The Netherlands | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Life Science | $100k–$10M |
|
Lansdowne Partners
VC Fund
|
2 | United Kingdom, Austria, United States | Series A, Series B | Biotechnology, Finance, Genetics | $6.8M–$100M |
|
Kale United
VC Fund
|
1 | United Kingdom, Sweden, India | Seed, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | |
|
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
|
1 | Germany, Austria | Seed, Series A | Electronics, Software, Medical Device | |
|
GLS Ventures
VC Fund
|
1 | Austria | Series B | Medical, Health Care, Biotechnology | |
|
Fund F
VC Fund
|
1 | Austria, United Kingdom | Pre-Seed, Seed | AgTech, EdTech, Software | |
|
Ligand Pharmaceuticals
VC Fund
|
1 | United States, Austria | Corporate Round, Post-IPO Debt, Series A | Health Care, Biotechnology, Medical | |
|
Gateway Ventures
VC Fund
|
1 | Germany, Austria, Estonia | Seed, Series A | Software, Information Technology, Apps | |
|
IPO Beteiligungs-Management
VC Fund
|
1 | Austria | Series B | Sensor, Medical, Wireless | |
|
PONTIS Venture Partners Management
VC Fund
|
1 | Austria, Germany | Series A, Series B, Series C | Software, Manufacturing, Information Technology | |
|
Matthias Wilrich
Angel
|
1 | Germany, Austria, Malaysia | Seed, Pre-Seed, Series A | E-Commerce, Delivery Service, Mobile Apps | |
|
Die Wirtschaftskammer
VC Fund
|
1 | Austria | Seed, Pre-Seed | Software, Music, mHealth | |
|
FCPG Affi
VC Fund
|
1 | Austria | Medical, Biotechnology, Pharmaceutical | ||
|
MCI Capital SA
VC Fund
|
1 | Poland, Germany, United Kingdom | Series A, Seed | E-Commerce, Software, Mobile | $603k–$9.4M |
|
Air Street Capital
VC Fund
|
1 | United States, United Kingdom, France | Seed, Series A, Series B | Artificial Intelligence, Software, Biotechnology | $2.6M–$300M |
|
Amino Collective
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $125k–$37M |
|
Hadean Ventures
VC Fund
|
1 | Norway, Sweden, Germany | Series A, Series B | Biotechnology, Health Care, Medical | $4.3M–$79M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
EMBL Ventures
VC Fund
|
1 | Germany, Austria, Ireland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.9M–$70M |
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $15M–$176M |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, France | Grant, Series C | Biotechnology, Health Care, Medical | $1.3M–$127M |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$120M |
|
OrbiMed
VC Fund
|
1 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$150M |
|
FastVentures
VC Fund
|
1 | Hungary, South Korea, United States | Seed, Series A, Series B | Software, Biotechnology, Information Technology | $424k–$31M |
|
Andera Partners
VC Fund
|
1 | France, United States, Germany | Series B, Private Equity | Biotechnology, Health Care, Medical | $14M–$247M |
| Access all 158 investors in Austria Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, France, Slovenia
Investor stats
- Total investments: 33
- Round size: Seed $576k–$5.9M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
- Lead/follow: 61% lead, 39% follow
Portfolio highlights
- Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
- Factorymaker — Factorymaker designs and analyzes sustainable, cost-efficient industrial layout and building proposals, guiding you through informed decisions at early design stage
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Slovenia
Investor stats
- Total investments: 22
- Round size: Seed $1.8M–$7.8M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- subdron — subdron turns the seabed from a blind spot into a monitored domain.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 62
- Round size: Seed $400k–$2.5M; Series A $583k–$6M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- eyeson — eyeson is a leader in cloud-based video conferencing with managed multipoint video processing technology at a scale. Based on its patented single stream technology, eyeson provides API video services to easily integrate video collaboration in business workflows for full customer engagement. eyeson is managing the cloud capacity, scalable videocoding performance and data management for the customer. Based on WebRTC technology, eyeson provides browser-based video meeting integrations on all desktop and mobile devices. eyeson offers B2B focused products used by Forbes 500 companies and named by Gartner as "cool vendor in unified communications."
- Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
- Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Grant, Pre-Seed
- Geography: Austria, Belgium
Investor stats
- Total investments: 59
- Round size: Seed $439k–$2.7M; Grant $62k–$603k; Pre-Seed $44k–$1.9M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Digicust — Extend your existing customs software by adding AI customs agents to automate customs declarations and save time and money.
- Repentium — Repentium serves industrial manufacturers seeking reproducible, cost-efficient 3D printing and engineering-grade plastic parts.
- Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: Germany, France, Austria
Investor stats
- Total investments: 96
- Round size: Series A $2.2M–$40M; Series B $1.6M–$54M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $70M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
Entrepreneur, Angel Investor, Scientist and Inventor
Show more...Investment focus
- Industry: mHealth, Software, Biopharma
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 7
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 85
- Round size: Seed $1.1M–$5.2M; Series A $1.1M–$12M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Upnano — Upnano engages in the manufacture and commercialization of 3D printing systems.
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
- vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
We are an early stage VC for climate tech startups.
Show more...Investment focus
- Industry: Software, Energy, Renewable Energy
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, Finland
Investor stats
- Total investments: 51
- Round size: Seed $2.2M–$6.2M; Pre-Seed $344k–$4.2M; Series A $2.7M–$12M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- UNOWN — Unown is a service and SaaS provider for the fashion industry. Our goal is to revolutionize the way we buy & sell clothing and thereby save 100,000 tons of CO2e every year. We believe that through our leasing, subscription and pre-loved services, we can use resources smarter and create higher value per asset.We enable brands to secure theirshare in the growing secondary markets. They lease out their assets through our revenue share model and get access to deep usage data. We enable customers to experience fashion with a completely new mindset. Our service allows them to rotate their wardrobe while maintaining an efficient and conscious lifestyle.
- Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
- Ostrom — We make energy fair, smart and green - one flexible monthly plan with no hidden fees, digital-first and 100% renewable energy.
Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 87
- Round size: Seed $2.7M–$12M; Pre-Seed $1.1M–$12M; Series A $6.9M–$60M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Raus — Raus is a hospitality-tech startup that offers new opportunities to take a break from big city life. Raus serves as a welcome escape from the seemingly endless demands and constant stimuli of modern life with perfectly simple cabins, close enough for a spontaneous getaway, far enough away to completely unwind.
- Magic — Teaching AI to act in its natural environment, the computer.
- Freeform — Freeform simplifies metal printing at any scale for all industries. Parts as a service to help you go from idea to production in days.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We back B2B software and life-sciences companies with limitless scalability.
Show more...Investment focus
- Industry: Software, Biotechnology, Telecommunications
- Stage:Seed, Series A
- Geography: Austria, Germany
Investor stats
- Total investments: 8
- Round size: Seed $1.6M–$4.4M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Txture — End-To-End Cloud Transformation Platform
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
- MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Seed
- Geography: Austria, United States, Germany
Investor stats
- Total investments: 29
- Round size: Seed $406k–$636k; Series A $1.3M–$8M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Icomasoft — Icomasoft ag is a Swiss pioneer of agent-less software solutions providing unprecedented transparency across your virtual and physical IT infrastructure in heterogeneous datacenters.IcomasoftÂ:registered: software solutions collect essential information for mission-critical and business-critical decisions and provide simplified, automated tasksthat support administrators, IT managers and Executives to easily and confidently analyze, plan and optimize their IT capacity. icomasoftÂ:registered: software solutions are vital for your datacenter clarity.
- Henn GmbH & Co KG — Henn GmbH & Co KG develops and commercializes rapid connecting systems for hoses in automotive engine blocks.
- CNSystems Medizintechnik — CNSystems Medizintechnik sells, manufactures, and develops equipment for non-invasive, continuous monitoring of blood pressure and other essential vital parameters. The company was founded in May 1998 as a spin-off from the Medical University and University of Technology Graz, Austria.
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
- Calyxha Biotechnologies GmbH — A new perspective on inflammation
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Austria
Investor stats
- Total investments: 30
- Round size: Seed $654k–$8M; Pre-Seed $439k–$2M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
- WiseWorks — AI-Powered Communications Intelligence for Financial Institutions
| Investments that move industries
Show more...Investment focus
- Industry: Software, Apps, Health Care
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 39
- Round size: Seed $650k–$8.1M; Series A $5M–$32M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Gustav — Modern staffing teams use Gustav's VMS to source talent from trusted sub-vendors. Fast, secure, and compliant!
- raicoon — SaaS solution for autonomous operations of renewable energy
- Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 119
- Round size: Seed $151k–$3.8M; Series A $30k–$5.9M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — SOLAR MATERIALS developed a recycling technology for solar modules, which recovers all raw materials for a circular solar industry.
- Litherm Technologies — Litherm Technologies GmbH is a German deep‑tech startup focused on decarbonizing lime and cement production using fully electric kiln technology.
The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Medical
- Stage:Grant, Seed, Pre-Seed
- Geography: Austria, United States, Belgium
Investor stats
- Total investments: 70
- Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
- sequestra — Sequestra is developing a technology platform that allows for permanent binding of CO₂ in industrial residues such as steel slag, incineration ash, and demolition waste while making the carbonated materials usable for construction applications.
- Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Chemical
- Stage:Series A, Series B
- Geography: United Kingdom, Austria, Belgium
Investor stats
- Total investments: 18
- Round size: Series A $1.5M–$20M; Series B $5.2M–$33M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Biocartis — Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus on oncology.
- Vivendy Therapeutics — Vivendy Therapeutics Ltd. has developed a specific recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) that is specifically modified to improve enzyme activity - enhancing the efficacy of the therapy in MPS IVA significantly
- Affectis Pharmaceuticals — Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
VP Venture Partners is a venture capital firm invests in healthcare companies.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, Internet
- Stage:Seed
- Geography: Austria, Switzerland
Investor stats
- Total investments: 3
- Round size: Seed $3M–$3.3M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Moonlight AI — Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight. Moonlight AI was founded in 2022 and is headquartered in Jura, Switzerland.
- aTension.life — aTension.life is a company focused on advancing the diagnosis and treatment of hypertension through precision medicine. It employs cutting-edge mass spectrometry technology to identify the underlying causes of uncontrolled hypertension using a single blood sample. aTension.life aims to provide personalized diagnostic solutions that enhance patientcare and support laboratories with accurate and reliable tools. The company's mission is to improve the quality of life for hypertensive patients by making advanced diagnostics widely accessible and enabling more effective, individualized therapies.
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 53
- Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $2.2M–$21M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: United States, China, Canada
Investor stats
- Total investments: 247
- Round size: Seed $500k–$7M; Series A $2M–$27M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Angle Health — Digital-First Health Plans For The Modern Employee
- BloomTech — BloomTech provides online technical coding courses including data science, full-stack web and backend development, and free coding courses.
- GiftedMom — GiftedMom - using mobile-based solutions to increase maternal engagement.
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Pre-Seed, Seed, Series A
- Geography: Switzerland, Germany, Israel
Investor stats
- Total investments: 69
- Round size: Seed $966k–$5M; Pre-Seed $583k–$2.1M; Series A $5M–$105M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Evoralis — Evoralis is an enzyme development company that specializes in the discovery and development of plastic-depolymerizing enzymes. It is a spin-out from the University of Cambridge.
- Proofcheck — Proofcheck is a multilingual AI proofreading platform and a collaborative in-browser workspace for PDFs and epubs. Their next-generation AI workflow and collaboration tool helps content creators quickly catch costly mistakes before they reach audiences. Proofcheck is headquartered in Vienna, Wien and was founded in 2022.
- Voliro — The multi-purpose robotic flight platform redefining work at height. NDT Solutions for elevated insights about your critical infrastructure.
Entrepreneurs for Entrepreneurs
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Austria, Switzerland
Investor stats
- Total investments: 57
- Round size: Seed $549k–$1.2M; Series A $768k–$6.6M
- Lead/follow: 79% lead, 21% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
- 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 85
- Round size: Seed $2M–$5.2M; Pre-Seed $573k–$2.4M; Series A $5M–$22M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Navidence — Navidence provides a transformative Real World Evidence (RWE) Design platform that enables organizations to efficiently adapt to the ever-increasing ecosystem of Real World Data (RWD) sources. The company unlocks the power of Computable Operational Definitions (CODefs) for RWE Design and RWD Assessment. Navidence's RWE Sherpa platform offerstools to streamline the process of defining an RWE study's data, making it easier for researchers to conduct their studies in the age of data.
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Sober Sidekick — Gamified peer to peer support
SPV
Show more...Investment focus
- Industry: Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 2
- Round size: Seed $420k–$429k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Investing globally in technologies extending healthy lifespans
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 49
- Round size: Seed $1.7M–$10M; Pre-Seed $100k–$3.2M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
- Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
- Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
Fundamental Equity Investing, since 1998
Show more...Investment focus
- Industry: Biotechnology, Finance, Genetics
- Stage:Series A, Series B
- Geography: United Kingdom, Austria, United States
Investor stats
- Total investments: 43
- Round size: Series A $6.8M–$55M; Series B $8.5M–$100M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
- G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
- amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Kale United offers a portfolio of over 75+ plant-based game changers
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Sweden, India
Investor stats
- Total investments: 22
- Lead/follow: no public data
Portfolio highlights
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- The Pack — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
- Cultimate Foods — Cultimate Foods is a cellular agriculture company. It develops cultivated fat for hybrid alt-meat products. It's cultivated fat replicates the structure of animal fat tissue and it uses a "unique technological approach to 3D cultivation that creates the structure of their ingredient and reduces production costs."
IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more...Investment focus
- Industry: Electronics, Software, Medical Device
- Stage:Seed, Series A
- Geography: Germany, Austria
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
- Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
- Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
GLS Ventures
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series B
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nabriva Therapeutics — MPOMM Adalah link resmi berlisensi agen mpo slot paling gacor hari ini dengan pilihan bermain di server slot anti rungkat terjamin kemenangan jackpot maxwin menang berapapun akan di bayar lunas
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The European Venture Fund that backs gender-diverse founder teams.
Show more...Investment focus
- Industry: AgTech, EdTech, Software
- Stage:Pre-Seed, Seed
- Geography: Austria, United Kingdom
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
- KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
- Willow Stories — Preserve your legacy and honor loved ones by creating lasting memorials.
A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Corporate Round, Post-IPO Debt, Series A
- Geography: United States, Austria
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Agenus — Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients
- invIOs — invIOs is a private biotechnology company that specializes in the discovery and development of next-generation cancer therapies that empower and educate the immune system to fight cancer.
- Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
Gateway Ventures is Austria's biggest network of startup investors with currently over 4000 investors. We foster the Austrian and European startup eco-system by connecting investors and startups. Our startup portfolio covers FinTech, CleanTech, HeathTech, IT & Software, Big Data & Social Impact. We have financed >40 startups withseed fundings over € 30M+Gateway Ventures was founded in December 2015. Over 1000 investors and 200 partners are currently participating in the network, including European incubators, accelerators and VCs.https://www.gateway.ventures
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Series A
- Geography: Germany, Austria, Estonia
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
- Pilzling — Bio-Pilze direkt aus deiner Stadt.
- LipoCheck — LipoCheck is a healthtech startup that focuses on improving the diagnosis and treatment of lipedema, a condition that affects millions of women. The company offers a digital platform that serves as a support system for patients and treating physicians. LipoCheck's services include helping patients recognize lipedema and providing assistance inbecoming symptom-free. The platform was developed with the experiences of practicing doctors, product managers, and software developers. In addition to its digital services, LipoCheck also offers a range of merchandise including hoodies and shirts.
IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.
Show more...Investment focus
- Industry: Sensor, Medical, Wireless
- Stage:Series B
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Austria, Germany
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Matthias Wilrich is the VP Vehicles and Supply Chain at TIER Mobility.
Show more...Investment focus
- Industry: E-Commerce, Delivery Service, Mobile Apps
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Austria, Malaysia
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Lumaly — Lumaly is a browser extension that automatically tries out and uses all available voucher codes in the cart when shopping online.
- MAYD — MAYD provides telepharmacy platform providing healthcare-related goods in a convenient way by delivering it to doorstep.
- HELLO INSIDE — HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies. Unlock your best self.
The Austrian Federal Economic Chamber functions as the federal parent organization for the nine State Chambers and 110 trade associations for different industries within Austria's system of economy.
Show more...Investment focus
- Industry: Software, Music, mHealth
- Stage:Seed, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Music Traveler — Music Traveler is a rapidly growing aggregator and marketplace, bringing a highly fragmented B2B and B2BC environment to the sharing economy. Music Traveler centralises practice/rehearsal/performing spaces, equipment, and instruction for the performing arts – its mission is to promote the creation, appreciation and interest in music byy reducing barriers, facilitating new interactions.
- The Apollinaire Group (TAG) — Intelligent supply chain management company.
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
FCPG Affi
Show more...Investment focus
- Industry: Medical, Biotechnology, Pharmaceutical
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.
Show more...Investment focus
- Industry: E-Commerce, Software, Mobile
- Stage:Series A, Seed
- Geography: Poland, Germany, United Kingdom
Investor stats
- Total investments: 41
- Round size: Seed $1.1M–$1.5M; Series A $603k–$9.4M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- IdoSell — IdoSell Shop is a complex service available in SaaS model directed to professional online shops and wholesale stores.
- Gett — Gett is a technology platform focused on corporate Ground Transportation Management (GTM), where spend is estimated to exceed $100 billion globally. https://gett.com/why We are the GTM category leader, serving over a quarter of the Fortune 500 companies.Gett’s cloud-based software organizes thousands of transportation providers(corporate fleet, ride-hailing, taxi, and limos) into one single platform. The technology helps save businesses time and money by managing all their ground transportation spend, and optimizes the entire employee experience from booking and riding to invoicing and analytics.We are building the first ground transportation grid available to customers worldwide, similar to telephony and internet grids, with aspirations to become the standard in corporate ground transportation, just as Zoom became the standard in corporate communication.Founded in 2010 and headquartered in London, Gett has raised more than $750M in funding to date, including more than $300M from the Volkswagen Group. They employ over 800 employees globally.
- ANSWEAR.com —
Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 44
- Round size: Seed $2.6M–$15M; Series A $5.7M–$33M; Series B $64M–$300M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
- Delian Alliance Industries — Building the digital backbone for the age of autonomous warfare.
- Interloom Technologies — Interloom is the first Navigation System for Work. It helps you map how your teams actually work. Grounded in this precedent, it guides your operational teams with suggested next steps and relevant context and empowers your AI agents to follow their lead.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 44
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
- Aware — Aware is a mobile app for evaluating health data and for researching chronic diseases.
- Nostos Genomics — Our genetic variant interpretation platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Norway, Sweden, Germany
Investor stats
- Total investments: 30
- Round size: Series A $4.3M–$79M; Series B $4.5M–$68M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $105M in 2021
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
- Centauri Therapeutics — At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: Germany, Austria, Ireland
Investor stats
- Total investments: 11
- Round size: Series A $3.9M–$15M; Series B $20M–$70M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
- Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 187
- Round size: Series A $16M–$176M; Series B $15M–$155M; Series C $19M–$113M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
- Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 121
- Round size: Grant $1.3M–$8.9M; Series C $10M–$127M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $319M in 2018
Portfolio highlights
- System — System is a free, open, and living public resource that aims to explain how anything in the world is connected to everything else.
- Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
- Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 309
- Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
- l'école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
- EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 589
- Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Crown Bioscience — Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for drug development. Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
venture capital
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Hungary, South Korea, United States
Investor stats
- Total investments: 26
- Round size: Seed $424k–$31M; Series A $1.3M–$2.3M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity
- Geography: France, United States, Germany
Investor stats
- Total investments: 179
- Round size: Series B $14M–$85M; Private Equity $110M–$247M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
- ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
- Greywolf Therapeutics — Novel antigen modulation technology that controls T cells to guide the immune system
Biotech Investor funding in Austria at a glance
Stats across 133 deals from 158 investors.
Access all 158 investors in Austria Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 158 investors investing in Austria Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!